Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05346991 · ClinicalTrials.gov registry record · NA

Disseminating an Evidence-based Tobacco Control Intervention for School Teachers in India

A NA study of Tobacco Use Cessation, sponsored by Glorian Sorensen.

Completed
Registry status
NA
Development phase
1,102
Enrollment target
2
Study locations

NCT05346991: Completed NA study of Tobacco Use Cessation, sponsored by Glorian Sorensen.

NCT05346991 is a NA study of Tobacco Use Cessation that has completed, run by Glorian Sorensen. The registered enrollment target is 1,102 participants, above the 854-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (29% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05346991, a NA study of Tobacco Use Cessation, has completed, sponsored by Glorian Sorensen.

COMPLETED
Registry status
NA
Development phase
1,102 participants
Enrollment target
2
Study locations

Study Summary

Disseminating an evidence-based tobacco control intervention for School Teachers

Primary Outcome

Self-administered Teacher's Survey completed by teachers. Using survey data, compute 7- and 30-day quit prevalence among teachers who reported using any tobacco in the last 9 months (the length of the academic year), and compare measures between intervention and control schools

Conditions Studied

Interventions

  • OTHER Tobacco Free Teachers, Tobacco Free Society program

Study Locations (2)

Massachusetts

  • Dana-Farber Cancer Institute - Boston

Other

  • Healis Sekhsaria Institute for Public Health - Mumbai

Trial Details

FieldValue
Enrollment Target 1,102 participants
Start Date 2018-06-01
Est. Completion 2020-07-31
Phase NA
Glorian Sorensen

1 total trials

What the finished NCT05346991 record still lists

NCT05346991 is an interventional study that assigns participants to a tested intervention. Its 1,102 participants enrollment target places it among the larger protocols in the corpus, above the 854-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (29% higher).

The record links to 1 condition, with Tobacco Use Cessation appearing as the primary indexed condition, and to 1 intervention - of which Tobacco Free Teachers, Tobacco Free Society program is the first listed.

NCT05346991 reports a single indexed study location in Massachusetts, Other.

Frequently Asked Questions

What is clinical trial NCT05346991 about?

NCT05346991 is a clinical study titled "Disseminating an Evidence-based Tobacco Control Intervention for School Teachers in India". Disseminating an evidence-based tobacco control intervention for School Teachers

What is the current status of trial NCT05346991?

This trial is currently completed. It is a NA study. The enrollment target is 1,102 participants. The study started on 2018-06-01. Estimated completion is 2020-07-31.

What conditions does trial NCT05346991 study?

This clinical trial studies the following conditions: Tobacco Use Cessation.

What interventions are being tested in trial NCT05346991?

The interventions under investigation include: Tobacco Free Teachers, Tobacco Free Society program (OTHER).

Who is sponsoring clinical trial NCT05346991?

This trial is sponsored by Glorian Sorensen, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05346991 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05346991's enrollment target sits among peer trials

1,102 11th of 36 higher than 26 of 36 other Tobacco Use Cessation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tobacco Use Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00710112 · 1,100 participants

    Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants

  • NCT02688517 · 1,100 participants

    Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

  • NCT04743765 · 1,100 participants · NA

    HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

  • NCT05638581 · 1,100 participants · Phase 3

    Trauma Resuscitation With Low-Titer Group O Whole Blood or Products

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05346991, the US trial registry maintained by the National Library of Medicine. NCT05346991 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.